Delta 9 Cannabis Inc (CVE:NINE – Get Rating) Director John William (John) Arbuthnot Iv purchased 70,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 31st. The stock was bought at an average cost of C$0.25 per share, for a total transaction of C$17,500.00. Following the completion of the acquisition, the director now directly owns 16,473,950 shares of the company’s stock, valued at C$4,118,487.50.
John William (John) Arbuthnot Iv also recently made the following trade(s):
- On Wednesday, May 25th, John William (John) Arbuthnot Iv sold 325,000 shares of Delta 9 Cannabis stock. The shares were sold at an average price of C$0.24, for a total transaction of C$76,375.00.
- On Friday, May 20th, John William (John) Arbuthnot Iv purchased 45,000 shares of Delta 9 Cannabis stock. The stock was bought at an average cost of C$0.25 per share, for a total transaction of C$11,250.00.
- On Wednesday, May 18th, John William (John) Arbuthnot Iv purchased 34,000 shares of Delta 9 Cannabis stock. The stock was bought at an average cost of C$0.25 per share, for a total transaction of C$8,500.00.
- On Monday, May 9th, John William (John) Arbuthnot Iv sold 75,000 shares of Delta 9 Cannabis stock. The shares were sold at an average price of C$0.24, for a total transaction of C$17,625.00.
- On Friday, May 6th, John William (John) Arbuthnot Iv sold 156,000 shares of Delta 9 Cannabis stock. The shares were sold at an average price of C$0.26, for a total transaction of C$40,560.00.
- On Tuesday, May 3rd, John William (John) Arbuthnot Iv sold 128,000 shares of Delta 9 Cannabis stock. The shares were sold at an average price of C$0.27, for a total transaction of C$34,560.00.
- On Friday, April 29th, John William (John) Arbuthnot Iv sold 145,000 shares of Delta 9 Cannabis stock. The stock was sold at an average price of C$0.28, for a total transaction of C$40,600.00.
- On Thursday, March 31st, John William (John) Arbuthnot Iv bought 144,750 shares of Delta 9 Cannabis stock. The shares were acquired at an average cost of C$0.28 per share, for a total transaction of C$40,530.00.
Shares of CVE:NINE traded up C$0.03 on Thursday, reaching C$1.03. 68,728 shares of the company’s stock were exchanged, compared to its average volume of 117,300. The firm has a market capitalization of C$89.36 million and a price-to-earnings ratio of 19.07. Delta 9 Cannabis Inc has a fifty-two week low of C$0.92 and a fifty-two week high of C$2.35. The business’s 50-day moving average is C$1.03 and its two-hundred day moving average is C$1.03. The company has a quick ratio of 2.04, a current ratio of 4.44 and a debt-to-equity ratio of 33.00.
Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.
See Also
- It’s A Comfortable Time To Buy Steelcase
- Worthington Posts Strong Results, But Earnings Fall On One-Off Adjustments
- A Tasty Entry Point Into Darden Restaurants International
- NXP Semiconductors: Strong Earnings & New Microcontrollers for Electric Vehicles
- Lithium Stocks Are Offering Unprecedented Opportunity To Investors
Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.